-O I Epstein Researcher Activity Profile

Research Author Detailed Information 

O I Epstein Publication Rate By Year

O I Epstein has published 38 paper(s) in 2003, 1 paper(s) in 2006, 1 paper(s) in 2007, 11 paper(s) in 2008, for a total of 51 research publications in total.

O I Oi Epstein Author Information

LAST NAME: epstein

FIRST NAME: O I

INITIALS: oi

AFFILIATION:

Papers

O I Epstein's Publication Record

1. Regulatory activity of ultralow doses. Year Published: 2003
2. Efficiency of ultralow doses of antibodies to s100 protein and delta sleep-inducing Peptide in rats with anxious depression. Year Published: 2003
Institute of Molecular Biology and Biophysics, Siberian Division of the Russian Academy of Medical Sciences, Novosibirsk; "Materia Medica Holding" Research-and-Production Company, Moscow.
3. Effect of antibodies to morphine in ultralow doses on induction of long-term potentiation in hippocampal slices from rats with chronic morphine dependence. Year Published: 2003
Institute of Molecular Biology and Biophysics, Siberian Division of the Russian Academy of Medical Sciences, Novosibirsk; "Materia Medica Holding" Research-and-Production Company, Moscow.
4. Effect of potentiated antibodies to morphine on behavioral reactions in rats with morphine dependence. Year Published: 2003
Institute of Neurology, Psychiatrics, and Narcology, Ukrainian Academy of Medical Sciences, Kharkov; "Materia Medica Holding" Research-and-Production Company, Moscow.
5. Effect of Preparations from Potentiated Ethanol on the Content of Biogenic Monoamines and Metabolism of Ethanol in Tissues of Rats during Alcoholization. Year Published: 2003
Institute of Neurology, Psychiatry, and Narcology, Ukrainian Academy of Medical Sciences, Kharkov; "Materia Medica Holding" Research-and-Production Company, Moscow.
6. Experimental Study of Antiblastic Activity in Potentiated Antibodies to Tumor Necrosis Factor-alpha. Year Published: 2003
Institute of Pharmacology, Tomsk Research Center, Siberian Division of the Russian Academy of Medical Sciences; "Materia Medica Holding" Research-and-Production Company, Moscow.
7. Effect of Potentiated Antibodies to Cyclophosphamide on the Development of Tumors and Effectiveness of Cytostatic Therapy under Experimental Conditions. Year Published: 2003
Institute of Pharmacology, Tomsk Research Center, Siberian Division of the Russian Academy of Medical Sciences; "Materia Medica Holding" Research-and-Production Company, Moscow.
8. Effect of allotransplantation of embryonic brain tissues and administration of potentiated antibodies to bombesin on hemodynamics in rats with emotional hypertension. Year Published: 2003
Institute of Neurology, Psychiatry, and Narcology, Ukrainian Academy of Medical Sciences, Kharkov; "Materia Medica Holding" Research-and-Production Company, Moscow.
9. Cytogenetic Effects of Antibodies to gamma-Interferon in Ultralow Doses. Year Published: 2003
Institute of Pharmacology, Tomsk Research Center, Siberian Division of the Russian Academy of Medical Sciences; "Materia Medica Holding" Research-and-Production Company, Moscow.
10. Ultralow Doses of Anti-Idiotypic Antibodies to Human gamma-Interferon: Immunotropic Properties. Year Published: 2003
Institute of Pharmacology, Tomsk Research Center, Siberian Division of the Russian Academy of Medical Sciences, Tomsk; "Materia Medica Holding" Research-and-Production Company, Moscow.
11. Immunotropic Effects of Potentiated Antibodies to Human Interferon-gamma. Year Published: 2003
Institute of Pharmacology, Tomsk Research Center, Siberian Division of the Russian Academy of Medical Sciences; "Materia Medica Holding" Research-and-Production Company, Moscow.
12. Erythropoietic activity of preparations containing receptors and antibodies to erythropoietin in ultralow doses. Year Published: 2003
Institute of Pharmacology, Tomsk Research Center, Siberian Division of the Russian Academy of Medical Sciences; "Materia Medica Holding" Research-and-Production Company, Moscow.
13. Erythropoietic activity of preparations containing receptors and antibodies to erythropoietin in ultralow doses. Year Published: 2003
Institute of Pharmacology, Tomsk Research Center, Siberian Division of the Russian Academy of Medical Sciences; "Materia Medica Holding" Research-and-Production Company, Moscow.
14. Effect of ultralow doses of antibodies to erythropoietin on antenatal and postnatal development of the offspring. Year Published: 2003
Institute of Pharmacology, Tomsk Research Center, Siberian Division of the Russian Academy of Medical Sciences; "Materia Medica Holding" Research-and-Production Company, Moscow.
15. Antiulcer Activity of Ultralow Doses of Antibodies to Histamine under Experimental Conditions. Year Published: 2003
Institute of Pharmacology, Tomsk Research Center, Siberian Division of the Russian Academy of Medical Sciences, Tomsk; "Materia Medica Holding" Research-and-Production Company, Moscow.
16. Analgesic and Antiinflammatory Activity of Antibodies to Histamine under Experimental Conditions. Year Published: 2003
Institute of Pharmacology, Tomsk Research Center, Siberian Division of the Russian Academy of Medical Sciences; "Materia Medica Holding" Research-and-Production Company.
17. Effects of ultralow doses of antibodies to prostate-specific antigen on morphological and functional state of rat prostate. Year Published: 2003
Institute of Pharmacology, Tomsk Research Center, Siberian Division of the Russian Academy of Medical Sciences; "Materia Medica Holding" Research-and-Production Company, Moscow.
18. Antitussive activity of anar. Year Published: 2003
All-Russia Research Center for Safety of Bioactive Substances, Staraya Kupavna; "Materia Medica Holding" Research-and-Production Company, Moscow.
19. Effect of Potentiated Solutions on Mercury(II) Signal in Inversion Voltammetry. Year Published: 2003
I. M. Gubkin Russian State University for Oil and Gas, Moscow; "Materia Medica Holding" Research-and-Production Company, Moscow.
20. Antibodies to delta sleep-inducing Peptide in ultralow doses: study of the effect by enzyme immunoassay. Year Published: 2003
Institute of Physiologically Active Substances, Russian Academy of Sciences, Chernogolovka; "Materia Medica Holding" Research-and-Production Company, Moscow.
21. Potentiated cyclophosphane: experimental study of the effect on tumor development and efficiency of cytostatic therapy. Year Published: 2003
Institute of Pharmacology, Tomsk Research Center, Siberian Division of the Russian Academy of Medical Sciences, Tomsk; "Materia Medica Holding" Research-and-Production Company, Moscow.
22. Membranotropic effects of antibodies to s100 protein in ultralow doses. Year Published: 2003
"Materia Medica Holding" Research-and-Production Company, Moscow; Kazan Physicotechnical Institute, Russian Academy of Sciences; Institute of Molecular Biology and Biophysics, Siberian Division of the Russian Academy of Medical Sciences, Novosibirsk.
23. Effects of Potentiated Antibodies Against Brain-Specific S100 Protein on Biogenic Amine Content and Lipid Peroxidation in Rats under Conditions of Alcoholization. Year Published: 2003
Institute of Neurology, Psychiatry, and Narcology, Ukrainian Academy of Medical Sciences, Kharkov; "Materia Medica Holding" Research-and-Production Company, Moscow.
24. Anxiolytic Effect of Proproten under Conditions of Punished and Unpunished Behavior. Year Published: 2003
"Materia Medica Holding" Research-and-Production Company, Moscow.
25. Antidepressant properties of proproten and amitriptyline: comparative experimental study. Year Published: 2003
"Materia Medica Holding" Research-and-Production Company, Moscow.
26. GABAergic system in the anxiolytic effect of proproten: experimental study. Year Published: 2003
"Materia Medica Holding" Research-and-Production Company, Moscow.
27. Neurotropic and neurospecific substances and their antibodies: effects on conditioned activity of rats. Year Published: 2003
Institute of Neurology, Psychiatrics, and Narcology, Ukrainian Academy of Medical Sciences, Kharkov; "Materia Medica Holding" Research-and-Production Company, Moscow.
28. Neurotropic compounds and their antibodies: effect on the brain system of positive emotional reinforcement. Year Published: 2003
Institute of Neurology, Psychiatrics, and Narcology, Ukrainian Academy of Medical Sciences, Kharkov; "Materia Medica Holding" Research-and-Production Company, Moscow.
29. Psychoactive compounds and their antibodies: effect on self-stimulation of the lateral hypothalamus in morphinized rats. Year Published: 2003
Institute of Neurology, Psychiatrics, and Narcology, Ukrainian Academy of Medical Sciences, Kharkov; "Materia Medica Holding" Research-and-Production Company, Moscow.
30. Potentiated antibodies against morphine: effects on biogenic amines and lipid peroxidation in chronically morphinized rats. Year Published: 2003
Institute of Neurology, Psychiatry, and Narcology, Ukrainian Academy of Medical Sciences, Kharkov; "Materia Medica Holding" Research-and-Production Company, Moscow.
31. Ultralow doses of antibodies to inflammatory mediators: antitussive properties of antibodies to bradykinin, histamine, and serotonin. Year Published: 2003
All-Russia Research Center for Safety of Biologically Active Substances, Staraya Kupavna; "Materia Medica Holding" Research-and-Production Company, Moscow.
32. Impaza and sildenafil: comparison of clinical effectiveness in patients with erectile dysfunction. Year Published: 2003
Volgograd Medical Academy; "Materia Medica Holding" Research-and-Production Company, Moscow.
33. Potentiated Antibodies to Tumor Necrosis Factor-alpha in the Therapy of Patients with Rheumatoid Arthritis. Year Published: 2003
Department of Therapy and Occupational Diseases, I. M. Sechenov Moscow Medical Academy; "Materia Medica Holding" Research-and-Production Company, Moscow.
34. Efficiency of Potentiated Antibodies to Tumor Necrosis Factor-alpha (Artrofoon) in the Therapy of Patients with Rheumatoid Arthritis. Year Published: 2003
Volgograd Medical Academy, Russian Ministry of Health; "Materia Medica Holding" Research-and-Production Company, Moscow.
35. Clinical efficiency of epigam in patients with exacerbation of peptic ulcer disease of the stomach and duodenum. Year Published: 2003
Volgograd Medical Academy; "Materia Medica Holding" Research-and-Production Company, Moscow.
36. Use of potentiated preparations to relieve alcohol and opium withdrawal syndromes. Year Published: 2003
Moscow Institute of Psychiatry, Russian Ministry of Health; "Materia Medica Holding" Research-and-Production Company, Moscow.
37. Proproten-100 in the therapy of patients with the alcohol withdrawal syndrome. Year Published: 2003
Moscow Institute of Psychiatry, Russian Ministry of Health; Russian State Medical University; Russian Medical Academy of Postgraduate Education, Russian Ministry of Health; "Materia Medica Holding" Research-and-Production Company, Moscow.
38. Changes in Immunological Parameters in Patients with Opium Abuse Receiving ANAR Therapy. Year Published: 2003
Laboratory of Clinical Psychoneuroimmunology, Department of Addictions, Institute of Mental Health, Tomsk Research Center, Siberian Division of the Russian Academy of Medical Sciences; Materia Medica Holding" Research-and-Production Company, Moscow.
39. Improvement of Memory by Means of Ultra-Low Doses of Antibodies to S-100B Antigen. Year Published: 2006
40. Stem cells in experimental chronic hepatitis. Year Published: 2007
Institute of Pharmacology, Tomsk Research Center, Russian Academy of Medical Sciences.
41. Comparison of the cardioprotective effects of cardos and losartan in rats with experimental chronic cardiac insufficiency. Year Published: 2008
Volgograd State Medical University, Federal Agency for Health Protection and Social Development.
42. Protective effect of low-doses of antibodies to s-100 protein on the formation of long-term sensitization in helix lucorum. Year Published: 2008
Materia Medica Company, Moscow; Institute of Molecular Biology and Biophysics, Siberian Division of Russian Academy of medical Sciences, Novosibirsk; Kazan Physical Technological Institute, Russian Academy of Sciences. gainutdinov@mail.knc.ru.
43. Involvement of the serotoninergic system in the mechanism of action of ultralow dose antibodies to s-100 protein. Year Published: 2008
Materia Medica Holding, Moscow. heifezia@materiamedica.ru.
44. Protective effect of low-doses of antibodies to S-100 protein on the formation of long-term sensitization in helix lucorum. Year Published: 2008
Materia Medica Company, Moscow, Russia.
45. Involvement of the serotoninergic system in the mechanism of action of ultralow dose antibodies to S-100 protein. Year Published: 2008
Materia Medica Holding, Moscow, Russia. heifezia@materiamedica.ru
46. Study of Antidiabetic Activity of a New Ultralow-dose Antibody Preparation on the Model of Streptozotocin Diabetes in Rats. Year Published: 2008
Volgograd State Medical University, Russian Ministry of Health; Materia Medica Holding, Moscow. heifezia@materiamedica.ru.
47. Study of antidiabetic activity of a new ultralow-dose antibody preparation on the model of streptozotocin diabetes in rats. Year Published: 2008
Volgograd State Medical University, Russian Ministry of Health, Moscow.
48. Antibodies to S100 proteins have anxiolytic-like activity at ultra-low doses in the adult rat. Year Published: 2008
Porsolt & Partners Pharmacology, 9 bis rue Henri Martin, 92100 Boulogne-Billancourt, France.
49. Comparison of the cardioprotective effects of cardos and losartan in rats with experimental chronic cardiac insufficiency. Year Published: 2008
Volgograd State Medical University, Federal Agency for Health Protection and Social Development.
50. Protective effect of low-doses of antibodies to S-100 protein on the formation of long-term sensitization in helix lucorum. Year Published: 2008
Materia Medica Company, Moscow, Russia.
51. Involvement of the serotoninergic system in the mechanism of action of ultralow dose antibodies to S-100 protein. Year Published: 2008
Materia Medica Holding, Moscow, Russia. heifezia@materiamedica.ru